- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | Novartis 'actively' reviewing relationships with Chinese contractors amid US biosecurity crackdown: CFO | ||
| Di | Life sci consulting firm Santander launches with offer of commercial strategy guidance | ||
| Di | Leqembi launch hamstrung by physicians' 'therapeutic nihilism' | ||
| Di | Novartis nominates former Bristol Myers CEO Giovanni Caforio as its new chair. Will M&A deals follow? | ||
| Mo | US Supreme Court rejects Vanda's bid to revive patents on sleep disorder drug Hetlioz | ||
| Mo | Sanofi's Zantac settlement is worth $100M, or $25K per claimant: Bloomberg | ||
| Mo | With $380M deal, Bristol Myers Squibb ups the ante with cell therapy manufacturer Cellares | ||
| Mo | Endo's Par Pharma issues recall of blood pressure med over possible contamination | ||
| Mo | Ahead of Alnylam's key heart disease readout, experts say Pfizer rival would be hard to displace | ||
| 19.04. | FibroGen settles with former employees who it claimed stole trade secrets | ||
| 19.04. | CSL Vifor proposes campaign to undo messaging about safety profile of rival product | ||
| 19.04. | Two-thirds of top 20 pharmas have banned ChatGPT-and many in life sci call AI 'overrated,' survey finds | ||
| 19.04. | Fierce Pharma Asia-Leqembi's cost to Medicare; Takeda's $1.2B-plus Kumquat deal; Fujifilm Diosynth's reorg | ||
| 19.04. | 'The Top Line': Winning formulas for the best biotech and drug names | ||
| 19.04. | AbbVie tops, J&J drops as physicians rank immunology players | ||
| 18.04. | Shinobi strikes deal with electronics powerhouse Panasonic to create new cell therapy manufacturing platform | ||
| 18.04. | Sanofi, busy with cost-savings campaign, restructures US commercial vaccine group | ||
| 18.04. | AstraZeneca's Alexion takes NMOSD awareness campaign long-form in new film highlighting community | ||
| 18.04. | After coming up short in COVID, Valneva focuses on chikungunya vaccine launch | ||
| 18.04. | Vanda turns back on hostile takeover bid by CDMO Future Pak | ||
| 18.04. | Novo Nordisk attracts lawmakers' scrutiny after dropping discounted insulin product Levemir | ||
| 18.04. | Lilly's Mounjaro, Zepbound supply situation worsens as most doses now face multi-month shortages | ||
| 18.04. | AbbVie touts Rinvoq win in giant cell arteritis, potentially teeing up another label expansion | ||
| 17.04. | Medincell, AbbVie link up in long-acting injectable development pact worth up to $1.9B | ||
| 17.04. | Pfizer's latest 'Dear Scientist' video stars a long COVID patient looking for answers |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
